Breast Cancer News and Research

Latest Breast Cancer News and Research

Study investigates the prevalence risk of familial dilated cardiomyopathy

Idiopathic dilated cardiomyopathy (DCM), the most common type of heart failure in the United States, was found to have a familial etiology in 30 percent of individuals diagnosed with DCM, and the overall risk for a family member of developing DCM was nearly 20 percent by the age of 80, according to a family-based, cross-sectional study published in JAMA.

22 Feb 2022

Many women experience confusion and distress after ductal carcinoma in situ diagnoses

Each year in the United States, nearly 50,000 women are diagnosed with ductal carcinoma in situ (DCIS), a non-invasive breast condition that cannot spread.

22 Feb 2022

‘Injections, injections, injections’: Troubling questions follow closure of sprawling pain clinic chain

On May 13 of last year, the cellphones of thousands of California residents undergoing treatment for chronic pain lit up with a terse text message: "Due to unforeseen circumstances, Lags Medical Centers will be closing effective May 19, 2021."

22 Feb 2022

MRI screenings may reduce breast-cancer mortality in women with 3 pathogenic gene variants

Annual MRI screenings starting at ages 30 to 35 may reduce breast-cancer mortality by more than 50% among women who carry certain genetic changes in three genes, according to a comparative modeling analysis to be published Feb. 17, 2022, in JAMA Oncology.

17 Feb 2022

New METPlatform allows researchers to test drugs for possible use in brain metastases

It is estimated that about a quarter of cancer patients are at risk of brain metastases, a rate that is increasing especially among those who suffer relapses after having undergone different cancer treatments.

17 Feb 2022

Locoregional treatment does not improve outcomes in women with stage IV breast cancer

Treating a tumor in the breast when distant metastases have already occurred does not improve outcomes in women with stage IV breast cancer, according to a new study published in the Journal of Clinical Oncology.

17 Feb 2022

Pandemic has led to delay in diagnosis of breast cancer

The COVID-19 pandemic upended many aspects of daily life, particularly in the first months and year. Not least among the changes: decreased use of ordinary health care, such as routine medical exams and screenings.

15 Feb 2022

Older woman's estrogen levels may be linked to risk of COVID-19 death

An older woman's estrogen levels may be linked to her chances of dying from COVID-19, with higher levels of the hormone seemingly protective against severe infection, suggests research published in the open access journal BMJ Open.

15 Feb 2022

U-M researchers measure out-of-pocket costs for follow-up tests after free cancer screening

With the White House putting cancer prevention and early treatment squarely in the sights of its renewed Cancer Moonshot initiative, recent University of Michigan research offers insights that policymakers could use to ensure more cancers are diagnosed earlier and reduce inequalities.

15 Feb 2022

Physicists investigate the usefulness of gene expression tests for cancer therapy

Following surgery, patients with breast cancer are faced with the question of whether additional chemotherapy is necessary and really effective.

14 Feb 2022

New insights into perspectives of older adults and caregivers on healthcare navigation, decision making

As part of an initiative funded by The John A. Hartford Foundation, FAIR Health conducted a nationwide study comprising two surveys geared toward older patients (adults 65 and older) and family caregivers/care partners.

12 Feb 2022

Research reveals why Black women experience higher breast cancer mortality

New research from Sanford Burnham Prebys has revealed significant molecular differences between the breast cells of white and Black women that help explain why Black women experience higher breast cancer mortality.

9 Feb 2022

30-year-old cancer drug could get another shot, study says

A study by Virginia Commonwealth University Massey Cancer Center researchers published in today's print edition of Molecular Cancer Therapeutics shows that triplatin is effective against triple negative breast cancer, which is the most aggressive form of breast cancer and has few targeted therapies.

9 Feb 2022

Study provides key information about the mechanism of breast cancer progression

Breast cancer is the most common cancer in women worldwide, yet despite medical advances, a cure for the tumors that spread locally and especially to distant sites remains out of reach.

7 Feb 2022

COVID-19 lockdown restrictions associated with increase in at-home drinking

Lockdown measures throughout 2020 have been linked to people in Scotland and England drinking more at home, according to new research.

4 Feb 2022

Better diagnostic tests needed to guide HER2 breast cancer treatment, study suggests

A new study by researchers at Yale Cancer Center shows using current standard human epidermal growth factor receptor 2 (HER2) assays as a diagnostic test may result in a mis-assignment of patients for treatment for breast cancer with a promising new drug.

3 Feb 2022

CECR2 gene inhibition prevents triple-negative breast cancer from metastasizing, study shows

A new study by researchers at Yale Cancer Center shows inhibition of the CECR2 gene prevents triple-negative breast cancer from advancing or metastasizing.

2 Feb 2022

Novel test uses cervical screening samples to detect breast and ovarian cancer

A new revolutionary test for detecting ovarian and breast cancer, which could potentially measure future cancer risk, is being developed by researchers from UCL's Institute for Women's Health.

2 Feb 2022

Experimental immunotherapy could help treat some people with metastatic breast cancer

An experimental form of immunotherapy that uses an individual's own tumor-fighting immune cells could potentially be used to treat people with metastatic breast cancer, according to results from an ongoing clinical trial led by researchers at the National Cancer Institute's Center for Cancer Research, part of the National Institutes of Health.

1 Feb 2022

Neural stem cells plus HER2 inhibitor drug improve survival in mice with metastatic cancer

Neural stem cells (NSCs) engineered by Northwestern Medicine investigators used in combination with the HER2 inhibitor drug tucatinib improved survival in mice with HER2-positive breast cancer brain metastases, according to findings published in Proceedings of the National Academy of Sciences.

1 Feb 2022

Breast Cancer News and Research

Latest Breast Cancer News and Research

Study investigates the prevalence risk of familial dilated cardiomyopathy

Many women experience confusion and distress after ductal carcinoma in situ diagnoses

‘Injections, injections, injections’: Troubling questions follow closure of sprawling pain clinic chain

MRI screenings may reduce breast-cancer mortality in women with 3 pathogenic gene variants

New METPlatform allows researchers to test drugs for possible use in brain metastases

Locoregional treatment does not improve outcomes in women with stage IV breast cancer

Pandemic has led to delay in diagnosis of breast cancer

Older woman's estrogen levels may be linked to risk of COVID-19 death

U-M researchers measure out-of-pocket costs for follow-up tests after free cancer screening

Physicists investigate the usefulness of gene expression tests for cancer therapy

New insights into perspectives of older adults and caregivers on healthcare navigation, decision making

Research reveals why Black women experience higher breast cancer mortality

30-year-old cancer drug could get another shot, study says

Study provides key information about the mechanism of breast cancer progression

COVID-19 lockdown restrictions associated with increase in at-home drinking

Better diagnostic tests needed to guide HER2 breast cancer treatment, study suggests

CECR2 gene inhibition prevents triple-negative breast cancer from metastasizing, study shows

Novel test uses cervical screening samples to detect breast and ovarian cancer

Experimental immunotherapy could help treat some people with metastatic breast cancer

Neural stem cells plus HER2 inhibitor drug improve survival in mice with metastatic cancer

Pharmaceutical Manufacturing - Industry Focus eBook eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Breast Cancer News and Research

Latest Breast Cancer News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in